Medicus Sciences Acquisition Corp. announced the pricing of its $80 million IPO this morning and its units are expected to begin trading on the Nasdaq under the symbol “MSACU” today, Tuesday, February 16.
The new company aims to combine with a business operating in the medical technology sector. Medicus Sciences is led by Executive Chairman Jacob Gottlieb, M.D., CEO Michael Castor, M.D., CFO Judah Drillick, and CBO Eric Cheng.
Total SPAC deal count for 2021 year-to-date is now 145 with $44.5 billion in gross proceeds raised. This offering is expected to close on Thursday, February 18.
Maxim Group LLC is acting as the sole book-running manager of the offering. Ellenoff Grossman & Schole LLP is serving as Issuer’s Counsel with Loeb & Loeb LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.